-
Mashup Score: 1
Skip Nav Destination June 27, 2022 Treatment with rivaroxaban was effective for managing splanchnic vein thrombosis (SVT) in non-cirrhotic patients, according to the results of a study published in Blood Advances. Study results suggest the oral…
Source: ashpublications.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 3Rivaroxaban for the treatment of noncirrhotic splanchnic vein thrombosis: an interventional prospective cohort study - 2 year(s) ago
Key Points. SVT is a potentially life-threatening disease associated with a substantial risk of recurrence and bleeding.Rivaroxaban appears to be a reasonable a
Source: American Society of HematologyCategories: Hem/Oncs, Latest HeadlinesTweet
#Rivaroxaban was effective for managing #splanchnic #vein #thrombosis in non-cirrhotic patients, with study results suggesting it could serve as an alternative to standard #anticoagulation https://t.co/W8KK1ANTId